CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Trachtenberg Eric SEE REMARKS | Returned to the company · Stock Option (right to buy) | −2,399 | 0 | ||
| 2023-05-31 | Trachtenberg Eric SEE REMARKS | Returned to the company · Stock Option (right to buy) | −1,813 | 0 | ||
| 2023-05-31 | Trachtenberg Eric SEE REMARKS | Returned to the company · Stock Option (right to buy) | −3,059 | 0 | ||
| 2023-05-31 | Trachtenberg Eric SEE REMARKS | Returned to the company · Stock Option (right to buy) | −648 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +14,736 | 26,619 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −1,841 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −578 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −1,399 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −2,999 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −2,399 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −1,813 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −3,059 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −648 | 0 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Grant or award | +17,916 | 36,452 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −308 | 0 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −2,047 | 0 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −942 | 0 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −1,399 | 0 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −2,999 | 0 | ||
| 2023-05-31 | Brazzell Romulus K SEE REMARKS | Returned to the company · Stock Option (right to buy) | −2,399 | 0 |
Page 9 of 12 · 236 trades